NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,409 | +188080.0% | 13,441 | +149244.4% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 9 | -99.9% | 0.00% | – |
| Q3 2022 | $4,000 | -60.0% | 6,113 | -34.8% | 0.00% | – |
| Q2 2022 | $10,000 | -84.4% | 9,372 | -72.7% | 0.00% | -100.0% |
| Q1 2022 | $64,000 | -31.2% | 34,290 | +77.9% | 0.00% | 0.0% |
| Q4 2021 | $93,000 | +232.1% | 19,273 | +395.2% | 0.00% | – |
| Q3 2021 | $28,000 | -45.1% | 3,892 | -29.2% | 0.00% | -100.0% |
| Q2 2021 | $51,000 | +264.3% | 5,499 | +399.9% | 0.00% | – |
| Q1 2021 | $14,000 | +75.0% | 1,100 | +87.1% | 0.00% | – |
| Q4 2020 | $8,000 | – | 588 | +6433.3% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 9 | -99.9% | 0.00% | -100.0% |
| Q2 2020 | $221,000 | +99.1% | 13,332 | +37.2% | 0.00% | +33.3% |
| Q1 2020 | $111,000 | -58.6% | 9,719 | -55.3% | 0.00% | -40.0% |
| Q4 2019 | $268,000 | – | 21,735 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 199,000 | $205,000 | 0.29% |
| Opaleye Management Inc. | 610,000 | $628,000 | 0.28% |
| Redmile Group, LLC | 3,436,935 | $3,540,000 | 0.14% |
| Kynam Capital Management, LP | 124,701 | $128,000 | 0.03% |
| Baker Brothers Advisors | 3,821,740 | $3,936,000 | 0.02% |
| Sio Capital Management, LLC | 38,312 | $39,000 | 0.02% |
| Candriam S.C.A. | 781,577 | $805,000 | 0.01% |
| Highland Private Wealth Management | 46,999 | $48,000 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 46,856 | $49,000 | 0.01% |
| Point72 Asset Management, L.P. | 1,437,417 | $1,481,000 | 0.01% |